A previous study demonstrated that the proliferation and migration abilities were markedly enhanced when FAM210B expression was knocked down in ovarian carcinoma SKOV3 cells and lung adenocarcinoma cancer A549 cells in vitro. Here, MIMS2 is linked to ovarian carcinoma.